Clinical Trials Logo

Endocrine System Disease clinical trials

View clinical trials related to Endocrine System Disease.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT02525887 Recruiting - Clinical trials for Cardiovascular Disease

Identify Genetic Variations That Affect The Ability of Patients To Metabolize Drugs Through Metabolic Pathways

Start date: July 2015
Phase: N/A
Study type: Observational

This observation will look at patient care decisions of the primary healthcare provider utilizing the results of the DNA testing of patients' metabolic pathways using 2C19, 2C9, 2D6, 3A4, Factor II, Factor V and MTHFR and VKORC1. Findings of the data collection will be published to optimize the benefits of pharmacogenomics testing and publish health outcomes.

NCT ID: NCT02202902 Recruiting - Clinical trials for Endocrine System Disease

Cardiac Steatosis in Cushing's Syndrome

CORTICOEUR
Start date: June 2014
Phase: N/A
Study type: Interventional

This study aims at evaluating the myocardial triglyceride content and cardiac structure and function, using 1H magnetic resonance spectroscopy and cardiac magnetic resonance imaging, in patients with Cushing's syndrome before and after treatment and in age-, sex- and BMI-matched healthy volunteers. The investigators make the hypothesis that Cushing's syndrome patients compared to healthy subjects present with excess lipid storage in cardiac myocytes, reversible upon correction of hypercortisolism.

NCT ID: NCT01317979 Recruiting - Diabetes Mellitus Clinical Trials

Asian Diabetes Surgery Study (ADSS): Clinical Predictor for the Success of Metabolic Surgery

ADSS
Start date: January 2011
Phase: N/A
Study type: Observational

Type 2 Diabetes Mellitus (T2DM) is a serious health problem that has increased dramatically worldwide due to the high and increasing prevalence of obesity. Medical management of T2DM is of limited success. Because not well controlled T2DM patients are in high risk of blindness, cardiovascular accident and end staged disease, T2DM has become a major health burden for society. Recent data on the relative effectiveness of gastrointestinal metabolic surgery played as bariatric surgery in the remission of T2DM, suggests that it may be significantly more effective than current medical treatment. In considering that less than half of the T2DM patients can achieve satisfactory treatment goal under current medical treatment, gastrointestinal metabolic surgery shall play an important role in T2DM treatment in the future. However, the indication for metabolic surgery and clinical predictors of success are not clear now. These clinical predictors can help us to choose appropriate not-well controlled T2DM patients to receive metabolic surgery and reduce dverse health outcomes in those patients.